{"title": "State of the European Union - Transparency in Europe 2016 and Beyond", "author": "Thomas Sullivan", "url": "https://www.policymed.com/2016/09/read-full-article-in-the-september2016-issue-of-life-science-compliance-update-to-read-the-full-story-subscribe-download-1.html", "hostname": "policymed.com", "description": "Three years ago, EFPIA adopted the EFPIA transparency code. Now three years later, this article takes the opportunity to look at what has happened so far with transparency reporting in Europe and what the future may hold.In June 2013, the EFPIA (Euro", "sitename": "Policy & Medicine", "date": "2016-09-15", "cleaned_text": "Three years ago, EFPIA adopted the EFPIA transparency code. Now three years later, this article takes the opportunity to look at what has happened so far with transparency reporting in Europe and what the future may hold. In June 2013, the EFPIA (European Federation of Pharmaceutical Industries and Associations) Statutory General Assembly adopted the \"EFPIA code.\" It is a code set by industry self-regulation, requiring the 33 national member associations to publicly report the transfers of value (ToV) made by pharmaceutical companies to physicians (HCPs), and healthcare organizations (HCOs). The underlying objective was to increase transparency around interactions between industry and HCPs and HCOs, proactively addressing potential concerns in society around these interactions. [Read Full Article in the September 2016 Issue of Life Science Compliance Update](http://www.lifescicompliance.com/) [Subscribe](http://www.lifescicompliance.com/subscription-options/), "}